Sage Therapeutics Inc.

NASDAQ: SAGE · Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM

Sage Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.82 -2.39 -4.49 -5.54
PEG Ratio
0.03 -0.36 -0.43 0.03
PS Ratio
8.00 15.00 294.29 395.66
PB Ratio
0.71 1.62 1.81 1.44
P/FCF Ratio
-1.23 -2.4 -4.91 -6.59
P/OCF Ratio
-1.23 -2.4 -4.92 -6.6
OCF/S Ratio
-6.48 -6.25 -59.85 -59.95
Debt / Equity Ratio
0.03 0.01 0.01 0.01
Quick Ratio
7.42 10.51 13.47 21.35
Current Ratio
7.42 10.51 12.82 21.14
Asset Turnover
0.08 0.10 0.01 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.86 -0.68 -0.4 -0.26
Return on Assets
-0.73 -0.61 -0.37 -0.25
Return on Invested Capital
-0.91 -0.72 -0.41 -0.26
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.77 0.98 0.89 0.91
Net Profit Margin
-9.71 -6.26 -65.48 -71.47
Pretax Profit Margin
-9.71 -6.26 -69.32 -72.59
Operating Profit Margin
-10.48 -6.71 -71.17 -73.07
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-9.93 -6.3 -71.02 -72.4